Mrv1652304062014132D 19 18 0 0 0 0 999 V2000 10048.290110048.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10049.007210048.8722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10049.721710048.4602 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 10050.436010048.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10051.150510048.4602 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10050.436010049.6970 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10047.576710048.8722 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 10046.861210048.4602 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 10046.147710048.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10046.861210047.6352 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10047.576710049.6970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10048.290110047.6352 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10049.721710047.6352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10050.437810047.2217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10051.870410047.2217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10051.154110047.6352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10052.586610047.6352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10052.586610048.4623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10053.302910047.2216 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 7 1 0 0 0 0 1 12 2 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 4 6 2 0 0 0 0 7 8 1 0 0 0 0 7 11 1 6 0 0 0 8 9 1 0 0 0 0 3 13 1 6 0 0 0 13 14 1 0 0 0 0 16 14 1 0 0 0 0 15 16 1 0 0 0 0 15 17 1 0 0 0 0 17 18 2 0 0 0 0 17 19 1 0 0 0 0 8 10 1 6 0 0 0 M END > BMDB0064069 > bmdb > C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O > InChI=1S/C10H21N5O4/c1-5(16)7(11)8(17)15-6(9(18)19)3-2-4-14-10(12)13/h5-7,16H,2-4,11H2,1H3,(H,15,17)(H,18,19)(H4,12,13,14)/t5-,6+,7+/m1/s1 > HYLXOQURIOCKIH-VQVTYTSYSA-N > C10H21N5O4 > 275.309 > 275.159354176 > 8 > 40 > 27.697365197571344 > 1 > 7 > 0 > 0 > (2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid > -3.59 > -4.30802438293955 > -2.42 > 0 > 0 > 1 > 13.546405171683574 > 3.5775289723284596 > 12.033716677953462 > 174.55 > 77.183 > 8 > 0 > 1.05e+00 g/l > (2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid > 0 > BMDB0064069 > Threonylarginine $$$$